| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2003-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a834dffe827b4f9afd4bce220c18c5a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0647b278a9529f7e6e000b495c7e785d |
| publicationDate |
2004-01-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004014772-A1 |
| titleOfInvention |
Compositions and methods for treating glomerular disorders |
| abstract |
Compositions and methods for treating a glomerular disorder. Compositions and methods comprise a cytochrome P450 inhibitor. Preferred inhibitors inhibit a cytochrome P450 2B family member. Compositions and methods reduce proteinuria associated with a glomerular disorder, such as, minimal change nephrotic syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005112123-A1 |
| priorityDate |
2000-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |